{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid46upxol7lrizueb3ijh5qfnk25goo7r3nkzqyklwhvpr6re6j4e",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mjmu4nndaoe2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihibwgp7eninozvfoqo4fi2ucehrattwlqleaxgy4zlhyjjjg4gb4"
    },
    "mimeType": "image/jpeg",
    "size": 74124
  },
  "path": "/2026/04/16/glp1-weight-loss-new-approach/?utm_campaign=rss",
  "publishedAt": "2026-04-16T15:58:16.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "In the Lab",
    "biotechnology",
    "drug development",
    "Obesity",
    "Pharmaceuticals",
    "STAT+",
    "weight loss"
  ],
  "textContent": "Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't actually necessary to achieve effective weight loss.",
  "title": "STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target",
  "updatedAt": "2026-04-16T15:58:21.000Z"
}